Literature DB >> 20629670

A presumptive new locus for autosomal dominant hypercholesterolemia mapping to 8q24.22.

A Cenarro1, A-L García-Otín, M T Tejedor, M Solanas, E Jarauta, C Junquera, E Ros, P Mozas, J Puzo, M Pocoví, F Civeira.   

Abstract

Molecular testing of patients with autosomal dominant hypercholesterolemia (ADH) fails to detect a causal functional mutation in 15.25% of subjects. We studied an ADH pedigree in which known ADH-causing genes (LDLR, APOB and PCSK9) were excluded. Genome-wide analysis on 15 family members detected significant association for ADH and dbSNP RS ID rs965814 (G/A), located in 8q24.22 cytoband. ADH was significantly associated to rs965814 G allele (p < 0.05) in a case-control study based on 200 unrelated ADH subjects without LDLR or APOB gene defects and 198 normolipidemic controls. We chose 24 markers for a detailed analysis of 8q24.22 cytoband, now based on an extended set of family members (21 individuals). One particular 24 marker haplotype was significantly associated to both higher total and low-density lipoprotein-cholesterol concentrations. Similar results were found for a shorter haplotype, composed of the distal six markers from the complete haplotype. Therefore, a presumptive new locus for ADH could be located in 8q24.22 cytoband, a region not previously linked or associated to ADH.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 20629670     DOI: 10.1111/j.1399-0004.2010.01485.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein Structure.

Authors:  Khalid Al-Waili; Ward Al-Muna Al-Zidi; Abdul Rahim Al-Abri; Khalid Al-Rasadi; Hilal Ali Al-Sabti; Karna Shah; Abdullah Al-Futaisi; Ibrahim Al-Zakwani; Yajnavalka Banerjee
Journal:  Oman Med J       Date:  2013-01

2.  Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Authors:  Marie Marduel; Khadija Ouguerram; Valérie Serre; Dominique Bonnefont-Rousselot; Alice Marques-Pinheiro; Knut Erik Berge; Martine Devillers; Gérald Luc; Jean-Michel Lecerf; Laurent Tosolini; Danièle Erlich; Gina M Peloso; Nathan Stitziel; Patrick Nitchké; Jean-Philippe Jaïs; Marianne Abifadel; Sekar Kathiresan; Trond Paul Leren; Jean-Pierre Rabès; Catherine Boileau; Mathilde Varret
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

3.  Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.

Authors:  Awatef Jelassi; Mohamed Najah; Afef Slimani; Imen Jguirim; Mohamed Naceur Slimane; Mathilde Varret
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

Review 4.  PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis.

Authors:  Qianyun Guo; Xunxun Feng; Yujie Zhou
Journal:  Front Genet       Date:  2020-09-23       Impact factor: 4.599

5.  Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation.

Authors:  Nabil G Seidah; Steve Poirier; Maxime Denis; Rex Parker; Bowman Miao; Claudio Mapelli; Annik Prat; Hanny Wassef; Jean Davignon; Katherine A Hajjar; Gaétan Mayer
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Authors:  Marta Futema; Vincent Plagnol; KaWah Li; Ros A Whittall; H Andrew W Neil; Mary Seed; Stefano Bertolini; Sebastiano Calandra; Olivier S Descamps; Colin A Graham; Robert A Hegele; Fredrik Karpe; Ronen Durst; Eran Leitersdorf; Nicholas Lench; Devaki R Nair; Handrean Soran; Frank M Van Bockxmeer; Steve E Humphries
Journal:  J Med Genet       Date:  2014-07-01       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.